drugset / Trial / NCT00174226

Treatment of Adult ADHD With Atomoxetine or Atomoxetine and Buspar

NCT00174226

Phase 2 Completed 241 enrolled Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

Determine if there is a difference in treatment response for adults with ADHD who are treated with Strattera versus those treated with a combination of Strattera and buspirone

Timeline

Start
2004-11
Primary completion
Completion
2006-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Atomoxetine Other / unclassified
Subject Buspirone Small molecule